R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse
NCT05257018
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
83
Enrollment
OTHER
Sponsor class
Conditions
Diffuse Large B-cell Lymphoma
Interventions
DRUG:
R-CDOP+intrathecal MTX
Sponsor
Fudan University